Pagliaro P, Arrigoni L, Muggiasca M L, Poggio M, Russo U, Rossi E
Servizio Trasfusionale e Laboratorio di Ematologia, Ospedale Luigi Sacco, Milan, Italy.
Am J Hematol. 1996 Sep;53(1):6-10. doi: 10.1002/(SICI)1096-8652(199609)53:1<6::AID-AJH2>3.0.CO;2-V.
Pregnancy in patients with primary thrombocythemia (PT) is reported to be often complicated by recurrent abortion and fetal growth retardation. Fifteen pregnancies in nine patients with PT are reported. Nine pregnancies had a good outcome, with the birth of a healthy infant. There were two spontaneous abortions and three intrauterine deaths. One pregnancy was electively terminated after extensive thrombosis in the splanchnic district requiring surgical entero-resection. In five pregnancies the mother received no treatment; in ten pregnancies acetylsalicylic acid (ASA) was prescribed to the mother as soon as she was found pregnant, subcutaneous heparin was added from the middle trimester in seven cases. In patients treated with ASA and subcutaneous heparin pregnancies had a good outcome. Administration of ASA and heparin during pregnancy appears to improve the outcome in patients with PT and can prevent severe maternal complications, but requires close monitoring.
据报道,原发性血小板增多症(PT)患者怀孕常并发反复流产和胎儿生长受限。本文报告了9例PT患者的15次妊娠情况。9次妊娠结局良好,产下健康婴儿。有2次自然流产和3次宫内死亡。1次妊娠在发生广泛的内脏区血栓形成并需要进行手术肠切除后选择性终止妊娠。5次妊娠中母亲未接受治疗;10次妊娠中,母亲一经发现怀孕即服用乙酰水杨酸(ASA),7例在孕中期开始加用皮下肝素。接受ASA和皮下肝素治疗的患者妊娠结局良好。孕期使用ASA和肝素似乎可改善PT患者的妊娠结局并预防严重的母体并发症,但需要密切监测。